0

.2

.4

.6

.8

1

0 5 10 15 20 25 30

Low risk

n=91

Median survival

17.5 years

Intermediate-1 risk

n=161

Median survival

6.8 yearsIntermediate-2 risk

n=150

Median survival

4.6 years

High risk

n=212

Median survival

2 years

Survival data among 614 Mayo Clinic patients with primary myelofibrosis risk-stratified by the International Prognostic Scoring System (IPSS)

(from time of within one year of diagnosis)

P<0.001

Years

Su

rviv

alSupplemental figure 1.

0

.2

.4

.6

.8

1

0 5 10 15 20 25 30

Low risk

n=91

Median survival

17.5 years

Intermediate-1 risk

n=225

Median survival

6.3 yearsIntermediate-2 risk

n=229

Median survival

2.7 years

High risk

n=69

Median survival

1.5 years

Survival data among 614 Mayo Clinic patients with primary myelofibrosis risk-stratified by the Dynamic International Prognostic Scoring System (DIPSS)

(from time of within one year of diagnosis)

P<0.001

Years

Su

rviv

alSupplemental figure 2.

0

.2

.4

.6

.8

1

0 5 10 15 20 25 30

Low risk

n=76

Median survival

19.2 years

Intermediate-1 risk

n=116

Median survival

8.1 years

Intermediate-2 risk

n=197

Median survival

4.7 years

High risk

n=195

Median survival

1.7 years

Survival data among 584 Mayo Clinic patients with primary myelofibrosis risk-stratified by the Dynamic International Prognostic Scoring System (DIPSS)-plus

(from time of within one year of diagnosis)

P<0.001

Years

Su

rviv

alSupplemental figure 3.